炎症性肠病与霍奇金淋巴瘤或多发性硬化症之间的流行病学关联
Amnon Sonnenberg1,2, Ruth Kohen3
1Section of Gastroenterology, Portland VA Medical Center, Portland, Oregon.
Gastro hep advances
|August 21, 2024
概括
霍奇金淋巴瘤 (HL) 和多发性硬化症 (MS) 与炎症性肠道疾病 (IBD) 共享风险因素,包括克罗恩病 (CD) 和性结肠炎 (UC). 地理和患者数据显示,这些情况经常同时发生,这表明有共同的潜在原因.
科学领域:
- 流行病学 流行病学
- 在瘤学瘤学.
- 神经学 神经学
- 胃肠病学 胃肠病学
背景情况:
- 流行病学研究表明,霍奇金淋巴瘤 (HL),多发性硬化症 (MS),克罗恩病 (CD) 和性结肠炎 (UC) 的共同危险因素.
- 这种共同的病因表明,这些不同疾病的地理分布和患者共同发生的潜在相似之处.
研究的目的:
- 调查美国各州HL,MS,CD和UC之间的地理相关性.
- 为了确定患者是否更有可能同时诊断出HL,MS,CD或UC,而不是偶然预期的.
主要方法:
- 一项横截面研究分析了医疗保险和医疗补助服务中心 (CMS) 人口中HL,MS,CD和UC的频率 (2018年).
- 通过统计相关性分析评估了四种诊断之间的地理相关性.
- 一项病例控制研究将任何两种诊断的观察到的同时发生与预期的频率进行了比较,使用几率比率和95%置信区间.
主要成果:
- 在四种疾病 (HL,MS,CD,UC) 的所有对之间发现了显著的正相关性,相关系数 (r) 从0.46到0.72不等 (P < .001).
- 炎症性肠病 (IBD) 与同时出现的HL (OR:1.22,95%CI:1.01-1.48) 和MS (OR:1.35,95%CI:1.25-1.46) 显著相关.
- 该研究分析了来自6,462,321名独特的CMS患者的数据,确定了8027名HL患者,42,934名MS患者,40,623名CD患者,32,521名UC患者.
结论:
- 观察到的IBD和HL或MS之间的流行病学关联表明它们的病因或发病过程中存在潜在的共同途径.
- 这些发现支持了影响这些疾病的分布和同时发生的共同风险因素的假设.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
206
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
206
Inflammatory Bowel Disease I: Ulcerative Colitis
160
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160
Chronic Bowel Disorders: Introduction
427
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
427
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Autoimmune Disorders
398
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
398
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120


